October 11, 2022
FDA Issues Draft Guidance on Protecting Children Who Participate in Clinical Trials
On September 26, 2022, the U.S. Food and Drug Administration (FDA) announced in the Federal Registry the newly published draft guidance titled, “Ethical Considerations for Clinical Investigations of Medical Products Involving Children.” The goal of this guidance is to provide FDA’s perspective on the ethical considerations for including children in clinical trials.